FOCL (Edap TMS) Other Current Liabilities: $3.4 Mil (As of Mar. 2026)


FOCL Edap TMS SA FOCL
53 GF Score
Price $5.08
GF Value $4.52
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Edap TMS Other Current Liabilities?

Edap TMS FOCL +1.91% 53 Other Current Liabilities is $3.4 Mil as of Mar. 2026. GuruFocus rates FOCL with a GF Score™ of 53/100 and a GF Value™ of $4.52 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Edap TMS's other current liabilities for the quarter that ended in Mar. 2026 was $3.4 Mil.

Edap TMS's quarterly other current liabilities declined from Sep. 2025 ($3.7 Mil) to Dec. 2025 ($3.3 Mil) but then increased from Dec. 2025 ($3.3 Mil) to Mar. 2026 ($3.4 Mil).

Edap TMS's annual other current liabilities increased from Dec. 2023 ($2.8 Mil) to Dec. 2024 ($3.4 Mil) but then declined from Dec. 2024 ($3.4 Mil) to Dec. 2025 ($3.3 Mil).

Edap TMS Other Current Liabilities Related Terms

Edap TMS Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Edap TMS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edap TMS Other Current Liabilities Chart

Edap TMS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.28 2.52 2.82 3.35 3.33

Edap TMS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 3.98 3.68 3.33 3.40
FOCL
53GF Score
Edap TMS SA FOCL
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edap TMS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $3.4 Mil mean?
Edap TMS (FOCL) has a Other Current Liabilities of $3.4 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Edap TMS.
Is Edap TMS's Other Current Liabilities too high?
Edap TMS's current Other Current Liabilities is $3.4 Mil. Overall, Edap TMS has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Edap TMS's Other Current Liabilities compare to ACH and YI?
Edap TMS's Other Current Liabilities of $3.4 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Distribution company?
A good Other Current Liabilities depends on the Medical Distribution industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Edap TMS. Edap TMS's current Other Current Liabilities is $3.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edap TMS stock overvalued right now?
Based on GuruFocus' analysis, Edap TMS (FOCL) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.52, compared to a current price of $5.08 — trading 12.3% above its estimated fair value. The current Other Current Liabilities is $3.4 Mil. Edap TMS's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Edap TMS (FOCL), the current Other Current Liabilities is $3.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edap TMS (FOCL) Overvalued in 2026?

Based on GuruFocus' analysis, Edap TMS stock appears to be overvalued. The current stock price of $5.08 is trading 12.3% above its estimated GF Value™ of $4.52. GuruFocus considers Edap TMS to be Modestly Overvalued.

Key valuation signals for FOCL:

  • Other Current Liabilities: $3.4 Mil
  • GF Value™: $4.52 vs. price of $5.08 (12.3% above fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the FOCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Edap TMS Business Description

Other Exchanges EDA:Germany
Address Parc d\'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
53GF Score

Get the complete analysis for FOCL

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.08
Price
$4.52
GF Value